Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kan Sun
Amanda S Azman

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Frontiers in Endocrinology|September 26, 2022
Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucoseKan Sun, Xianchao Xiao, Lili You, et al.
Clinical Science (London, England : 1979)|April 17, 2019
Endothelial cell-derived small extracellular vesicles suppress cutaneous wound healing through regulating fibroblasts autophagyTingting Zeng, Xiaoyi Wang, Wei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2016
E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaMatthew E Spector, Assuntina G Sacco, Emily Bellile, et al.
Journal of Epidemiology and Community Health|January 8, 2022
Association of education levels with the risk of hypertension and hypertension control: a nationwide cohort study in Chinese adultsKan Sun, Diaozhu Lin, Mian Li, et al.
Zhonghua Nei Ke Za Zhi|January 19, 2013
[The baseline characteristics of patients with type 2 diabetes initiating insulin detemir : the Chinese cohort from the SOLVE(TM) study]Chang-yu Pan, Li-nong Ji, Ju-ming Lu, et al.
Zhonghua Nei Ke Za Zhi|May 29, 2013
[The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study]Chang-yu Pan, Li-nong Ji, Ju-ming Lu, et al.
BMC Medicine|October 9, 2023
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trialMingtong Xu, Kan Sun, Wenjie Xu, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Frontiers in Endocrinology|September 26, 2022
Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucoseKan Sun, Xianchao Xiao, Lili You, et al.
Clinical Science (London, England : 1979)|April 17, 2019
Endothelial cell-derived small extracellular vesicles suppress cutaneous wound healing through regulating fibroblasts autophagyTingting Zeng, Xiaoyi Wang, Wei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2016
E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaMatthew E Spector, Assuntina G Sacco, Emily Bellile, et al.
Journal of Epidemiology and Community Health|January 8, 2022
Association of education levels with the risk of hypertension and hypertension control: a nationwide cohort study in Chinese adultsKan Sun, Diaozhu Lin, Mian Li, et al.
Zhonghua Nei Ke Za Zhi|January 19, 2013
[The baseline characteristics of patients with type 2 diabetes initiating insulin detemir : the Chinese cohort from the SOLVE(TM) study]Chang-yu Pan, Li-nong Ji, Ju-ming Lu, et al.
Zhonghua Nei Ke Za Zhi|May 29, 2013
[The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study]Chang-yu Pan, Li-nong Ji, Ju-ming Lu, et al.
BMC Medicine|October 9, 2023
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trialMingtong Xu, Kan Sun, Wenjie Xu, et al.
Pageof 12